Pls read the discussion below and write a one-page response paper with 2 new ideas to support this discussion or add to it. It must be supported with 2 scholarly references. No introduction needed
Week 9 Initial Discussion Post
This week’s case study involves a 68-year-old male patient with multiple health comorbidities and a recent community-acquired pneumonia diagnosis. He is responding well to his treatment with the prescribed antibiotics with an improvement in his condition but remains unable to tolerate a diet due to nausea and vomiting. Although he needs to remain on treatment for his other comorbidities, the focus is to successfully treat his active pneumonia case with the prescribed antibiotics and offer medications to help improve his dietary intake by decreasing his nausea and vomiting. Caution should be taken knowing the patient has COPD, HTN, and diabetes that can all worsen when the body is stressed with a new disease process. Close observation will be necessary with the patient on Ceftriaxone with his Penicillin allergy, but at this time patient has tolerated the treatment without any adverse side effects.
Treatment Regimen and Pharmacotherapeutics
Developing a treatment regimen is essential to providing this patient with the best care to ensure he recovers from his pneumonia. Educating the patient that he will need to continue the treatment with his prescribed antibiotics is of priority, with the recommendations that treatment should continue for a minimum of five days (Yi et al., 2018). I would recommend the patient remain on his currently prescribed antibiotics since he has had an improvement in his condition since initiation three days prior. Since the patient has become more clinically stable, a transition to oral antibiotic therapy can be initiated, helping to shorten the length of his hospital visit (Gasparetto et al., 2019). The addition of medication for nausea could be discussed, if necessary, but careful consideration would be needed because the antibiotic Azithromycin has interactions with several standard antiemetics that could result in heart arrhythmias that could prove fatal (Albert et al., 2014). The patient’s current home medications for COPD, HTN, hyperlipidemia and diabetes are not disclosed in the case study, but medication interactions with any new medications being implemented should be verified before treatment.
Patient Education Strategy
As an APRN, it is vital to work together with patients ensuring they understand their diagnosis, the disease process, and the available treatment options. Patient education is a priority to achieve the best possible outcomes utilizing evidence-based practice. Collaboration between health care providers and patients promotes open communication and shared decision-making, benefiting treatment success. One patient education strategy to use would be improved health literacy, which allows patients the opportunity to seek, understand, and utilize health information to promote positive changes and outcomes in their health (Paterick et al., 2017). The patient should be informed of all treatment options with the risks and benefits discussed to participate in their care. Any questions the patient might have should be addressed promptly in terms that the patient could understand. Providing the patient with a treatment plan they can follow, which includes the course of the disease process, the expected length of treatment, and available resources to assist them will achieve better outcomes.
Albert, R. K., Schuller, J. L., & COPD Clinical Research Network. (2014). Macrolide antibiotics and the risk of cardiac arrhythmias. American journal of respiratory and critical care medicine, 189(10), 1173–1180. https://doi.org/10.1164/rccm.201402-0385CI
Gasparetto, J., Tuon, F.F., dos Santos Oliveira, D. (2019). Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units. BMC Infect Dis 19, 650. https://doi.org/10.1186/s12879-019-4280-0
Paterick, T. E., Patel, N., Tajik, A. J., & Chandrasekaran, K. (2017). Improving health outcomes through patient education and partnerships with patients. Proceedings (Baylor University. Medical Center), 30(1), 112–113. https://doi.org/10.1080/08998280.2017.11929552
Yi, S.H., Hatfield, K.M., Baggs, J., Hicks, L.A., Srinivasan, A., Reddy, S., Jernigan, J.S. (2018). Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States, Clinical Infectious Diseases, Volume 66, Issue 9, 1 May 2018, Pages 1333–1341, https://doi.org/ 10.1093/cid/cix98